Efficacy of gabapentin mouthwash in managing oral mucositis pain in patients undergoing chemotherapy: a prospective, randomised, double-blind, controlled clinical trial
Scottish Medical Journal · 2020-02 · 65 (1) · 12-18
DOI: 10.1177/0036933019897237 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Scottish Medical Journal, online erschienen am 30.01.2020. Verfasst von Shahram Ala und 5 weiteren Autor:innen. Beteiligte Einrichtung: Professor of Clinical Pharmacy, Department of Clinical Pharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Vice Chancellor of Research of Mazandaran University of Medical Sciences.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background and aims Gabapentin has been used for the management of radiotherapy and chemotherapy induced stomatitis in a number of studies. Due to lack of sufficient evidence, the present study was designed to evaluate the efficacy of gabapentin mouthwash in oral mucositis associated pain in patients undergoing cancer chemotherapy. Methods and results This study was a prospective, randomised, double-blind, placebo-controlled trial. The patients were randomly divided into two groups receiving either the gabapentin or placebo mouthwash. Patients were advised to rinse their mouth with 7 ml of solution for 30 s three times a day and were visited 10 days after initiation of the trial. The intensity of pain and severity of oral mucositis were assessed. Thirty-one patients received gabapentin mouthwash while 27 patients received placebo. Both gabapentin and placebo mouthwashes had decreased the pain intensity almost equally and did not show a significant difference between the two groups (P = 0.73). Also both gabapentin and placebo had reduced and improved swallowing, inflammation and erythema. But there was no noticeable difference between groups (P > 0.05). Conclusions These findings indicate that gabapentin mouthwash did not show a significant activity as a pain relieving agent in chemotherapy induced oral mucositis associated pain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Professor of Clinical Pharmacy, Department of Clinical Pharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
- Pharmacy Student, Students Research Committee, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
- Professor of Pharmaceutics, Department of Pharmaceutics, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
ORCID-Profile: Neda Koulaeinejad
Förderung
- Vice Chancellor of Research of Mazandaran University of Medical Sciences
Zitieren
APA
Ala, S., Zamani, N., Akbari, J., Salehifar, E., Janbabai, G., & Koulaeinejad, N. (2020). Efficacy of gabapentin mouthwash in managing oral mucositis pain in patients undergoing chemotherapy: a prospective, randomised, double-blind, controlled clinical trial. Scottish Medical Journal, 65(1), 12-18. https://doi.org/10.1177/0036933019897237
Vancouver
Ala S, Zamani N, Akbari J, Salehifar E, Janbabai G, Koulaeinejad N. Efficacy of gabapentin mouthwash in managing oral mucositis pain in patients undergoing chemotherapy: a prospective, randomised, double-blind, controlled clinical trial. Scottish Medical Journal. 2020;65(1):12-18. doi:10.1177/0036933019897237
BibTeX
@article{Ala2020,
author = {Ala, Shahram and Zamani, Neda and Akbari, Jafar and Salehifar, Ebrahim and Janbabai, Ghasem and Koulaeinejad, Neda},
title = {Efficacy of gabapentin mouthwash in managing oral mucositis pain in patients undergoing chemotherapy: a prospective, randomised, double-blind, controlled clinical trial},
journal = {Scottish Medical Journal},
year = {2020},
volume = {65},
number = {1},
pages = {12--18},
doi = {10.1177/0036933019897237}
}
EUVIMED